(Q39753573)

14 September 2017

title

GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro (English)

1 reference

14 September 2017

1 reference

2

0 references

Irving Vidaurre

series ordinal

5

object named as

Irving Vidaurre

1 reference

14 September 2017

1

Szabolcs Bellyei

1 reference

14 September 2017

Marta Zarandi

3

1 reference

14 September 2017

Jozsef L Varga

series ordinal

4

1 reference

14 September 2017

Eva Pozsgai

series ordinal

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

12 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

293

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

31-40

1 reference

Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene

14 September 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Peptide analogs in the therapy of prostate cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Invasion and metastasis markers in cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Intercellular adhesion, signalling and the cytoskeleton

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone in oncology

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

beta-catenin signaling and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

LH-RH analogues: I. Their impact on reproductive medicine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

GnRH analogs reduce invasiveness of human breast cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The metastatic cascade in prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Cancer statistics, 2008

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Identifiers

DOI

10.1016/J.CANLET.2009.12.014

1 reference

14 September 2017

1 reference